Investors see big Novo stock boost if weight-loss drug Wegovy shows heart benefit
Positive trial data showing Novo Nordisk’s obesity drug helps save and extend lives, not just lose weight, could propel Europe’s best-performing stock even higher, according to 10 investors and industry…